Timothy Clay

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients

Takuya Osada, Gabriel T. Chong, Robert Tansik et al. · Cancer Immunology Immunotherapy · 2008 · 304 citations · Full text

Hematological Malignancy, Medicine, Malignant Blood Disorder +11

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet · 2017 · 175 citations · Full text

Platinum-based Therapy, Urology, Metastatic Urothelial Carcinoma +8

Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients

Michael A. Morse, Robert Chapman, John D. Powderly et al. · Clinical Cancer Research · 2011 · 140 citations · Full text

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Daniel P. Petrylak, Ronald de Wit, Kim N. et al. · The Lancet Oncology · 2019 · 83 citations · Full text

Platinum-based Therapy, Urology, Genitourinary Cancer +8

NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity

Takuya Osada, Timothy Clay, Amy Hobeika et al. · Cancer Immunology Immunotherapy · 2005 · 71 citations · Full text

Vaccination, Immunology, Therapeutic Vaccine +11